All data are based on the daily closing price as of October 7, 2025
h

Hyundai Bioscience

048410.KQ
3.78 USD
0.04
+1.07%

Overview

Last close
3.78 usd
Market cap
363.25M usd
52 week high
7.58 usd
52 week low
3.17 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
272.7842
Price/Book Value
4.4724
Enterprise Value
339.48M usd
EV/Revenue
257.0805
EV/EBITDA
-64.6317

Key financials

Revenue TTM
1.32M usd
Gross Profit TTM
55415.96 usd
EBITDA TTM
-10.09M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
88.53M usd
Net debt
N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
  • Symbol
    048410.KQ
  • Exchange
    KQ
  • Isin
    KR7048410005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Jong-Won Choi
  • Headquarter
    Seoul
  • Web site
    https://www.hyundaibioscience.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top